These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1527789)

  • 1. Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTIC.
    Lowe PR; Sansom CE; Schwalbe CH; Stevens MF; Clark AS
    J Med Chem; 1992 Sep; 35(18):3377-82. PubMed ID: 1527789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCMCIT, an analogue of the antitumour drugs mitozolomide and temozolomide.
    Lowe PR; Schwalbe CH
    Acta Crystallogr C; 1994 Oct; 50 ( Pt 10)():1629-31. PubMed ID: 7986429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNA.
    Clark AS; Stevens MF; Sansom CE; Schwalbe CH
    Anticancer Drug Des; 1990 Feb; 5(1):63-8. PubMed ID: 2317259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies.
    Brown GD; Luthra SK; Brock CS; Stevens MF; Price PM; Brady F
    J Med Chem; 2002 Dec; 45(25):5448-57. PubMed ID: 12459013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs.
    Arrowsmith J; Jennings SA; Clark AS; Stevens MF
    J Med Chem; 2002 Dec; 45(25):5458-70. PubMed ID: 12459014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.
    Clark AS; Deans B; Stevens MF; Tisdale MJ; Wheelhouse RT; Denny BJ; Hartley JA
    J Med Chem; 1995 Apr; 38(9):1493-504. PubMed ID: 7739008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour imidazotetrazines. Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor groove.
    Arrowsmith J; Missailidis S; Stevens MF
    Anticancer Drug Des; 1999 Jun; 14(3):205-17. PubMed ID: 10500496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of dual-action agents of a beta-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide.
    Wang Y; Lambert P; Zhao L; Wang D
    Eur J Med Chem; 2002 Apr; 37(4):323-32. PubMed ID: 11960667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.
    Dive C; Workman P; Watson JV
    Cancer Chemother Pharmacol; 1989; 25(3):149-55. PubMed ID: 2557170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Acid derivative of the antitumour agent mitozolomide.
    Lowe PR; Schwalbe CH
    Acta Crystallogr C; 1995 May; 51 ( Pt 5)():937-9. PubMed ID: 7779325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour imidazotetrazines--XVI. Macromolecular alkylation by 3-substituted imidazotetrazinones.
    Bull VL; Tisdale MJ
    Biochem Pharmacol; 1987 Oct; 36(19):3215-20. PubMed ID: 2444229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.
    Denny BJ; Wheelhouse RT; Stevens MF; Tsang LL; Slack JA
    Biochemistry; 1994 Aug; 33(31):9045-51. PubMed ID: 8049205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphs and polymorphic cocrystals of temozolomide.
    Babu NJ; Reddy LS; Aitipamula S; Nangia A
    Chem Asian J; 2008 Jul; 3(7):1122-33. PubMed ID: 18512823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
    Tsang LL; Quarterman CP; Gescher A; Slack JA
    Cancer Chemother Pharmacol; 1991; 27(5):342-6. PubMed ID: 1998993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
    Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA
    Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual case of desmotropy. Combined spectroscopy (¹H-¹⁴N NQDR) and quantum chemistry (periodic hybrid DFT/QTAIM and Hirshfeld surface-based) study of solid dacarbazine (anti-neoplastic).
    Latosińska JN; Latosińska M; Seliger J; Žagar V; Burchardt DV; Derwich K
    Solid State Nucl Magn Reson; 2015; 68-69():13-24. PubMed ID: 25936462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation.
    Zucchetti M; Catapano CV; Filippeschi S; Erba E; D'Incalci M
    Biochem Pharmacol; 1989 Jul; 38(13):2069-75. PubMed ID: 2660797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism.
    Tisdale MJ
    Br J Cancer; 1985 Nov; 52(5):789-92. PubMed ID: 3864485
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.
    Stevens MF; Hickman JA; Stone R; Gibson NW; Baig GU; Lunt E; Newton CG
    J Med Chem; 1984 Feb; 27(2):196-201. PubMed ID: 6694168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
    Baer JC; Freeman AA; Newlands ES; Watson AJ; Rafferty JA; Margison GP
    Br J Cancer; 1993 Jun; 67(6):1299-302. PubMed ID: 8512814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.